The compound is called cannabizetol (CBGD), and it’s only the fourth dimeric cannabinoid ever identified in cannabis. When researchers tested it against 84 different inflammatory genes, it showed significantly higher anti-inflammatory activity than any previously studied dimeric cannabinoid. It works through the NF-κB pathway—essentially a master switch for inflammation throughout the human body—and exhibits powerful antioxidant properties that could have applications in dermatology, chronic inflammation, and potentially dozens of other medical conditions we haven’t even imagined yet.
Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…
State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…
Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…
Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…
The FDA is seeking outside data and analytics services to better understand how people use…